Pharma Investments, Ventures & Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures & Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Chesapeake Corporation
Chesapeake Corporation Announces Bankruptcy Court Approval of Sale to Investor Group
April 12th, 2009
Chesapeake Corporation (BULLETIN BOARD: CSKEQ) announced that the U.S. Bankruptcy Court for the Eastern District of Virginia in Richmond entered an order approving the sale of its operating businesses to a group of investors, including affiliates of Irving Place Capital Management, L.P. and Oaktree Capital Management, L.P. The transaction remains subject to the satisfaction of standard and customary conditions of closing, including the receipt of regulatory approvals. The company expects the transaction to close by mid-April 2009. The company's financial advisor is Goldman Sachs & Co., its restructuring advisor is Alvarez & Marsal, and its legal...
Source: Pharma Investments, Ventures & Law Weekly (2009-04-12)
|
